Uroepithelial Carcinoma

2

Review clinical trials related to Uroepithelial Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trop2-targeted immunoPET Imaging of Solid Tumors

This study aims to establish and optimize the trophoblast cell surface antigen 2 (Trop2)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging method and its physiological and pathological distribution characteristics, based on which the diagnostic efficacy of the above imaging agents in solid tumors (including uroepithelial cancer, bladder cancer, prostate cancer, lung cancer, nasopharyngeal cancer, liver cancer, cholangiocarcinoma, ovarian cancer, cervical cancer, endometrial cancer, thyroid cancer, head and neck cancer) will be evaluated.

Participants needed: 400
Trial details
Phase: Phase 2, Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: RenJi HospitalUpdated: May 29, 2026Locations: 1
Eligibility criteria

Aged 18-75 year-old and of either sex [+2]

Pregnancy; [+2]

Status: Not yet recruiting

Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province

Participants needed: 400
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital of Xinxiang Medical CollegeUpdated: Oct 29, 2024Locations: 11Duration: 400 Days
Eligibility criteria

Adults ≥18 years of age (at enrollment) [+3]

Incomplete medical history and medical records